ULTRAGENYX PHARMACEUTICAL IN (RARE)

US90400D1081 - Common Stock

41.87  -0.74 (-1.74%)

After market: 41.87 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
442.63M434.25M363.30M351.40M271.00M
Cost Of Goods
50.48M45.21M28.30M16.00M6.10M
Gross Profit
392.14M389.04M335.00M335.40M264.90M
Operating Expenses
972.54M958.25M983.90M717.10M595.00M
Research and Development
661.14M644.65M702.60M496.90M411.90M
Selling, General, and Administrative Expenses
311.29M309.80M278.10M220.00M182.90M
Operating Income
-580.50M-569.21M-648.90M-381.70M-330.10M
Interest Income/Expense
33.71M27.09M-8.20M-40.10M177.40M
Other Income/Expense
-68.54M-66.34M-44.60M-31.10M-32.70M
Income Before Taxes
-615.22M-608.46M-701.70M-453.00M-185.40M
Income Tax
-1.85M-1.82M5.70M1.00M1.20M
Net Income
-613.27M-606.64M-707.40M-454.00M-186.60M
EBITDA
-550.88M-543.20M-630.68M-368.46M-317.84M
 
Per Share Data
EPS Diluted Total Ops
-8.02-8.25-10.12-6.70-3.07
Non GAAP EPS
-8.03-8.33-10.11-6.71-3.00
 
Statistics
Gross Profit Margin
88.59%89.59%92.21%95.45%97.75%
Profit Margin
-138.55%-139.70%-194.72%-129.20%-68.86%
Operating Profit Margin
-131.15%-131.08%-178.61%-108.62%-121.81%

All data in USD

Charts